1. Home
  2. TMDX vs COTY Comparison

TMDX vs COTY Comparison

Compare TMDX & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • COTY
  • Stock Information
  • Founded
  • TMDX 1998
  • COTY 1904
  • Country
  • TMDX United States
  • COTY United States
  • Employees
  • TMDX N/A
  • COTY N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • COTY Package Goods/Cosmetics
  • Sector
  • TMDX Health Care
  • COTY Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • COTY Nasdaq
  • Market Cap
  • TMDX 4.0B
  • COTY 3.3B
  • IPO Year
  • TMDX 2019
  • COTY 2013
  • Fundamental
  • Price
  • TMDX $122.80
  • COTY $3.55
  • Analyst Decision
  • TMDX Buy
  • COTY Hold
  • Analyst Count
  • TMDX 11
  • COTY 17
  • Target Price
  • TMDX $130.73
  • COTY $5.77
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • COTY 5.7M
  • Earning Date
  • TMDX 10-29-2025
  • COTY 11-05-2025
  • Dividend Yield
  • TMDX N/A
  • COTY N/A
  • EPS Growth
  • TMDX 170.70
  • COTY N/A
  • EPS
  • TMDX 2.54
  • COTY N/A
  • Revenue
  • TMDX $566,354,000.00
  • COTY $5,798,600,000.00
  • Revenue This Year
  • TMDX $38.84
  • COTY $1.27
  • Revenue Next Year
  • TMDX $20.46
  • COTY $2.55
  • P/E Ratio
  • TMDX $48.16
  • COTY N/A
  • Revenue Growth
  • TMDX 41.20
  • COTY N/A
  • 52 Week Low
  • TMDX $55.00
  • COTY $3.54
  • 52 Week High
  • TMDX $145.50
  • COTY $8.04
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.90
  • COTY 29.68
  • Support Level
  • TMDX $115.21
  • COTY $4.10
  • Resistance Level
  • TMDX $125.57
  • COTY $4.16
  • Average True Range (ATR)
  • TMDX 7.60
  • COTY 0.15
  • MACD
  • TMDX -1.02
  • COTY -0.05
  • Stochastic Oscillator
  • TMDX 28.37
  • COTY 4.20

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About COTY Coty Inc.

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake as of June 2025.

Share on Social Networks: